Literature DB >> 32777027

Tapering Antipsychotic Treatment.

Mark Abie Horowitz1,2, Robin M Murray3, David Taylor3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 32777027     DOI： 10.1001/jamapsychiatry.2020.2166

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  7 in total

1.  Confounding of Antipsychotic Discontinuation Studies by Withdrawal-Related Relapse.

Authors:  Mark Abie Horowitz; Robin M Murray; David Taylor
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 9.306

2.  A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse.

Authors:  Mark Abie Horowitz; Sameer Jauhar; Sridhar Natesan; Robin M Murray; David Taylor
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 7.348

3.  Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication.

Authors:  Miriam Larsen-Barr; Fred Seymour
Journal:  Ther Adv Psychopharmacol       Date:  2021-01-31

4.  Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation-Is It Feasible to Develop Evidence-Based Guidelines?

Authors:  Graham Blackman; Ebenezer Oloyede; Mark Horowitz; Robert Harland; David Taylor; James MacCabe; Philip McGuire
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 9.306

5.  Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists' Attitudes in Taiwan.

Authors:  Ko Yen; Chen-Chung Liu; Yi-Ting Lin; Yi-Ling Chien; Ming H Hsieh; Chih-Min Liu; Tzung-Jeng Hwang; Wei-Hsiang Liao; Hai-Gwo Hwu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-03-01       Impact factor: 2.570

6.  Minding metabolism: targeted interventions to improve cardio-metabolic monitoring across early and chronic psychosis.

Authors:  John R Kelly; Priyola Gounden; Aoibheann McLoughlin; Zahra Legris; Therese O'Carroll; Roisin McCafferty; Liliana Marques; Maeve Haran; Richard Farrelly; Karen Loughrey; Gráinne Flynn; Aiden Corvin; Catherine Dolan
Journal:  Ir J Med Sci       Date:  2021-03-08       Impact factor: 1.568

7.  Predictors of Lack of Relapse After Random Discontinuation of Oral and Long-acting Injectable Antipsychotics in Clinically Stabilized Patients with Schizophrenia: A Re-analysis of Individual Participant Data.

Authors:  Georgios Schoretsanitis; John M Kane; Christoph U Correll; Jose M Rubio
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.